** Atomo Diagnostics AT1.AX soars as much as 11.1% to A$0.020; biggest intraday gain since Dec. 5, 2024
** Medical devices maker executes new long-term supply agreement for its HIV self-test device
** Five-year deal with existing distribution partner Newfoundland Diagnostics worth ~A$5.4 mln ($3.4 mln)
** Deal grants Newfoundland exclusive distribution rights to supply Atomo's test in the UK and non-exclusive rights for the EU and Colombia
** AT1 up 5.3% YTD
($1 = A$1.6184)
(Reporting by Adwitiya Srivastava in Bengaluru)
((Adwitiya.Srivastava@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。